VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $57,280,470 | -9.2% | 2,960,231 | 0.0% | 18.66% | -13.5% |
Q3 2022 | $63,083,000 | +56.6% | 2,960,231 | 0.0% | 21.57% | +67.2% |
Q2 2022 | $40,289,000 | -41.9% | 2,960,231 | 0.0% | 12.90% | -34.4% |
Q1 2022 | $69,299,000 | -11.8% | 2,960,231 | 0.0% | 19.66% | +3.3% |
Q4 2021 | $78,535,000 | +52.9% | 2,960,231 | 0.0% | 19.03% | +63.3% |
Q3 2021 | $51,360,000 | +33.4% | 2,960,231 | 0.0% | 11.66% | -2.1% |
Q2 2021 | $38,513,000 | – | 2,960,231 | – | 11.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 5,450,000 | $74,719,500 | 8.73% |
Kynam Capital Management, LP | 2,956,053 | $40,527,487 | 6.63% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 758,355 | $10,381,880 | 3.50% |
Sofinnova Investments, Inc. | 3,467,156 | $47,534,709 | 3.00% |
Altium Capital Management LP | 333,681 | $4,574,767 | 2.39% |
Eversept Partners, LP | 1,478,489 | $20,270,084 | 1.72% |
SECTORAL ASSET MANAGEMENT INC | 357,139 | $4,896,376 | 0.95% |
Carlyle Group Inc. | 1,438,155 | $19,688,342 | 0.85% |
Orbimed Advisors | 1,518,115 | $20,813,357 | 0.44% |
Woodline Partners LP | 2,562,600 | $35,133,246 | 0.41% |